Clinical trial
The "AFFORD" Study: Atrial Fibrillation/Flutter Outcome Risk Determination
NCT01138644 is registered in ClinicalTrials.gov with Vanderbilt University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The "AFFORD" Study: Atrial Fibrillation/Flutter Outcome Risk Determination
- Lead sponsor
- Vanderbilt University
- Phase
- Observational
- Overall status
- Completed
- Start date
- June 30, 2010
- Completion date
- April 30, 2015
- Enrollment
- 519 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.